Summary
The U.S. Food and Drug Administration has approved British drugmaker GSK’s asthma drug to treat some patients with a chronic lung disease commonly known as “smoker’s lung”, the company said on Thursday.
Source: Reuters on MSN.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
